COPPARONI, CECILIA
 Distribuzione geografica
Continente #
NA - Nord America 279
EU - Europa 103
AS - Asia 53
AF - Africa 13
SA - Sud America 7
Totale 455
Nazione #
US - Stati Uniti d'America 278
IT - Italia 26
IE - Irlanda 21
SG - Singapore 21
RU - Federazione Russa 19
SE - Svezia 17
CN - Cina 15
CI - Costa d'Avorio 10
HK - Hong Kong 9
BR - Brasile 7
DE - Germania 7
FI - Finlandia 4
UA - Ucraina 3
GB - Regno Unito 2
IN - India 2
MA - Marocco 2
TR - Turchia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
FR - Francia 1
HN - Honduras 1
KR - Corea 1
NL - Olanda 1
PK - Pakistan 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 455
Città #
Chandler 40
Des Moines 40
Ashburn 21
Dublin 17
Boardman 15
Fairfield 15
Woodbridge 15
New York 12
Singapore 12
Abidjan 10
Hong Kong 9
Houston 7
Seattle 7
Wilmington 7
San Diego 6
Cambridge 5
Lawrence 5
Princeton 5
Redmond 5
The Dalles 5
Turin 5
Jacksonville 4
Ancona 3
Moscow 3
Munich 3
San Mateo 3
Santa Clara 3
Tolentino 3
Turku 3
Washington 3
Ann Arbor 2
Beijing 2
Centro 2
Civitanova Marche 2
Los Angeles 2
Pune 2
Wuhan 2
Amsterdam 1
Baku 1
Boston 1
Campinas 1
Cedar Knolls 1
Clifton 1
Denver 1
Dhaka 1
Duncan 1
El Progreso 1
Falconara Marittima 1
Fermignano 1
Helsinki 1
Islamabad 1
Islington 1
Jaboatão dos Guararapes 1
Jinan 1
Johannesburg 1
Manchester 1
Newark 1
Nova Iguaçu 1
Nuremberg 1
Odesa 1
Perugia 1
Phoenix 1
Prague 1
Qingdao 1
Quanzhou 1
Rio Claro 1
Rondonópolis 1
Saint Petersburg 1
Seoul 1
Shenzhen 1
Stockholm 1
Suzano 1
São Paulo 1
Tianjin 1
Totale 342
Nome #
Prospective observational study of taste assay in patients with solid tumors treated with standard chemotherapy (POTATO) 106
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis 101
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma 95
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 78
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab 51
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study 42
Totale 473
Categoria #
all - tutte 3.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.100


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 0 0 0 0 0 14
2020/202150 2 1 3 8 8 2 0 5 7 4 5 5
2021/202253 2 3 0 1 15 5 2 3 10 4 2 6
2022/2023148 5 17 5 10 9 52 0 3 19 2 17 9
2023/202479 15 2 4 6 11 26 0 1 0 1 1 12
2024/2025129 29 9 2 6 8 10 10 4 21 7 21 2
Totale 473